Transmissible spongiform encephalopathies (TSEs), or prion diseases, are neurodegenerative disorders of humans and animals. A key molecular event in prion diseases is the conversion of a cellular prion protein (PrP C ) into a diseaseassociated misfolded conformer (PrP d ) . Whereas PrP C is fully sensitive to in vitro proteolysis, PrP d is only partly degraded (PrP res ) by the removal of its N-terminal end. The molecular features of PrP res revealed by Western blot analysis are thought to be associated with the strain of infectious agent involved in the disease (Telling et al., 1996) . Proteinase K (PK) digestion is generally used for the diagnosis of prion diseases and for molecular discrimination of TSE strains, such as BSE and scrapie, by Western blot analysis (Baron et al., 2008) . Another method, based on protease thermolysin (TL), has recently been reported to permit the isolation of a PK-sensitive fraction of PrP d in its full-length form (Cronier et al., 2008; Owen et al., 2007b) . It has been suggested that such an approach might facilitate the molecular discrimination of TSE sources, especially BSE and an unusual form of scrapie known as CH1641 that shares some molecular similarities with BSE (Hope et al., 1999) . The accumulation of endogenous prion fragments in the brain of TSE-affected animals or humans, in the absence of in vitro proteolysis, has also been investigated in several studies, by Western blot analysis and also by immunohistochemistry (Chen et al., 1995; Jeffrey et al., 2003 Jeffrey et al., , 2006 Jiménez-Huete et al., 1998; Owen et al., 2007b; Yadavalli et al., 2004) .
In the present study, we applied Western blot analyses to a large panel of ovine and bovine TSE sources transmitted to an ovine transgenic mouse model (TgOvPrP4) ( Table 1 ) in order to assess (i) the endogenous PrP molecules in the brain and (ii) the compared effects of in vitro proteolysis with PK or TL. PrP extractions using ultracentrifugation and Western blot analyses have been described previously (Baron et al., 2004 (Baron et al., , 2008 ; . Two modifications were included in this study: (i) absence of protease digestion prior to ultracentrifugation and (ii) use of TL instead of PK. To prevent artefactual PrP proteolysis, brain samples were frozen immediately after death and stored at 280 u C. For the TL digestion, aliquots of 10 % (w/v) brain homogenates in lysis buffer [0.5 % (v/v) Nonidet P-40 and 0.5 % (v/v) sodium deoxycholate in 15 mM KH 2 PO 4 , 81 mM Na 2 HPO 4 , 137 mM NaCl and 3 mM KCl] were digested with 1 mg thermolysin ml 21 h 21 added each hour for a total of 4 h at 70 u C prior to ultracentrifugation. All results are shown (i) after enzymic deglycosylation of PrP prior to immunoblotting, using the recombinant PNGase F kit (New England BioLabs) as described previously , in order to precisely analyse the PrP cleavage products, and (ii) after PrP detection using horseradish peroxidase-labelled SAF84 antibody (500 ng ml
21
; SPI-Bio) against the 167-RPVDRY-172 ovine sequence, to detect possible Cterminal PrP fragments (Baron et al., 2008) .
The endogenous prion protein, isolated from the brain in the absence of PK digestion was first analysed by Western blot analysis (Fig. 1) . In the uninfected mouse control (Fig.  1a) , three bands of PrP C of~26, 20 and 17 kDa were detected, corresponding to the full-length (FL) protein and to the C2 and C1 cleaved PrP C fragments, respectively. As previously described in humans or in experimental models, the predominant cleavage product was C1, although several studies had, like ours, also reported low levels of C2 in uninfected brain and cell lines (Chen et al., 1995; Jiménez-Huete et al., 1998; Mangé et al., 2004; Yadavalli et al., 2004) . As this C2 fragment possesses the amyloidogenic region of PrP, it has been assumed that it could represent a 'substrate' that might be directly converted into PrP d or incorporated into PrP d aggregates (Chen et al., 1995) .
The situation appeared strikingly different in TSE-infected mice, and the predominant fragment was C2. Indeed, the analyses of PrP in TgOvPrP4 mice inoculated with bovine prions (Fig. 1a ) that included classical and 'atypical' BSEs (H-type and L-type), as well as transmissible mink encephalopathy (TME) experimentally transmitted to cattle, showed (i) that the PrP pattern in BSE-H inoculated mice and uninfected mice were similar, in relation to the Chandler Baron & Biacabe, 2007 C506M3 Baron & Biacabe, 2007 Baron et al., , 2008 absence of transmission of H-type BSE in TgOvPrP4 mice , (ii) that the C2 fragment, of~19 kDa, was predominant in BSE-C, BSE-L and TME, whereas C1 was only present in small amounts, or undetectable. These observations matched with previously reported studies of TSE-infected human, murine and ovine tissues or cellculture models (Chen et al., 1995; Jiménez-Huete et al., 1998; Owen et al., 2007b; Yadavalli et al., 2004) . The levels of C2 and of PrP res are known to increase during prion infection (Yadavalli et al., 2004) . Hence, our data from TgOvPrP4 mice also faithfully reproduced the various intracellular proteolytic processing events that occur with the disease-associated PrP protein.
The analyses of PrP from experimental scrapie sources (Fig.  1b) , including strains 87V, 79A, Chandler and C506M3, and the CH1641 and SSBP/1 isolates, showed (i) the accumulation of a C2 fragment of~19 kDa in CH1641 and 87V, instead of the~20 kDa in SSBP/1, 79A, Chandler and C506M3, and (ii) the presence of an additional PrP fragment of~14 kDa, designated 'CTF14', only in CH1641 and 87V. Western blot analysis also revealed a~19 kDa C2 fragment and the presence of CTF14 in five 'CH1641-like' natural scrapie isolates (Fig. 1c) . These features of the endogenous prion protein were compared, from representative prion sources (bovine BSE-C and ovine SSBP/1 or CH1641 scrapie isolates) (Fig. 1d) , to those of the PrP res_PK isolated after PK digestion. In TSE-infected mice, the main PrP res_PK products migrated at either~19 (BSE-C and CH1641) or~20 kDa (SSBP/1), like the C2 fragment that faithfully reflected the strain-specific differences. An additional~14 kDa PrP res_PK product was also identified solely in the CH1641 scrapie isolate, as was the endogenous CTF14 fragment.
Our study thus indicated that the features of the cleaved PrP fragments directly detected from the brain were TSE strain-specific even in the absence of in vitro protease digestion. The mobility of the C2 fragment consistently differed according to the TSE source, occurring either as ã 19 or~20 kDa band, as observed with PrP res obtained after PK digestion. Action of proteases post-mortem or during laboratory procedures unlikely contributes to our findings, since it was shown in infected cell cultures that the proportions of full-length, C2 and C1 fragments did not depend on the use of protease inhibitors (Yadavalli et al., 2004) . In sporadic Creutzfeldt-Jakob disease (CJD), the C2 fragment was reported to be slightly longer (22.5 kDa) in type-1 CJD than in type-2 CJD (21-22 kDa), reminiscent of the differences observed after PK digestion (Jiménez-Huete et al., 1998). Also, Parchi et al. (2000) reported in these two CJD subtypes, by protein sequencing of PrP res , the existence of two distinct major PK cleavage sites. In sheep, immunohistochemistry studies indicated that the N-terminal end of PrP d from BSE and from CH1641, compared with other scrapie sources such as SSBP/1, was more strongly digested (Jeffrey et al., 2006) . Consistently, Western blot analyses in sheep recently showed that C2 fragments could be detected in SSBP/1, but not in CH1641 and BSE, when an N-terminal (P4) antibody was used (Owen et al., 2007b) . However, the novelty in our study is the description of another endogenous, more C-terminally cleaved, PrP fragment of 14 kDa in its unglycosylated form, which we have called CTF14. The presence of this CTF14 fragment appeared to be TSE strain-specific, since it was only detected in CH1641, in 'CH1641-like' natural scrapie isolates and in the 87V scrapie strain. This CTF14 fragment actually corresponded to the C-terminal PK-resistant PrP res # 2 we recently described in 'CH1641-like' scrapie (Baron et al., 2008) . Similar C-terminal prion fragments have been described after PK digestion in H-type BSE, in cattle and after its transmission in C57BL/6 mice , and in some molecular subtypes of sporadic CJD in humans (Notari et al., 2008; Zou et al., 2003) , which suggests the involvement of common proteolytic pathways in these disorders. It is unclear whether this fragment is generated from full-length PrP or from pre-existing truncated PrP species. A study reported that synthetic amyloid fibrils of recombinant PrP contained a C-terminal PK-resistant core composed of residues 152-230 or 162-230 (Bocharova et al., 2005) . The authors speculated that this reflected an intrinsic property of PrP, since no cellular factors or templates were used for the generation of the amyloid fibrils in vitro. Interestingly, we (see below) and others (Owen et al., 2007a) have also identified a PrP C fragment of~14 kDa more resistant to TL digestion in uninfected animals. It is also unknown if the pathological production of the CTF14 occurs in different cell types or brain regions, compared to the C2 fragment. Immunohistochemical approaches could help to resolve this issue as they already demonstrated different PrP truncations in different cell types -or extracellularly -in BSE and scrapie (Jeffrey et al., 2003) .
We then chose to examine the behaviour of PrP following digestion by TL, as it was recently reported to act differently depending on the TSE source, compared with the generally used PK digestion (Owen et al., 2007b; Cronier et al., 2008) .
We first determined that efficient degradation of fulllength PrP C was obtained by digesting uninfected TgOvPrP4 mouse brain homogenates with 1 mg TL ml 21 h 21 for 4 h at 70 u C, although low levels of a resistant 14 kDa PrP C fragment were also identified (Fig. 2b) . This is consistent with the finding of a TL-resistant~22 kDa PrP C species, without deglycosylation and specifically detected using C-terminal antibodies, previously reported by others in healthy sheep (Owen et al., 2007a) .
We then investigated the molecular features of PrP res_TL in TSE-infected mice (Fig. 2a, b ), in comparison with those observed following PK digestion (Fig. 2c, d ). PrP res_TL showed two major bands, one of~19 (CH1641, 87V, BSE-L, BSE-C and TME) or~20 kDa (SSBP/1, 79A, Chandler and C506M3) and the other one of~14 kDa, these PrP products being similar to those observed following digestion with PK. The~14 kDa band was abundant only in CH1641 and 87V, but a similar band remained detected at low levels in all the other experimental groups and in uninfected mice. In comparison with PK digestion, PrP res_TL was much more abundant in BSE-C than in the other TSEs, and included not only the major~19 kDa band, but also a 'smear' of less truncated PrP species between~19 and~26 kDa. TL thus produced truncated PrP res_TL fragments with similar features to those detected after PK digestion, but also in the absence of any protease digestion, i.e. the~19 or~20 kDa band in all TSE sources, and the abundant~14 kDa band in CH1641 and 87V. Owen et al. (2007b) suggested that CH1641 might show remarkable features after TL digestion, since they failed to detect any PrP res_TL , but confirmed the presence of PrP res_PK in the same sample. However, the absence of a PrP res_TL signal corresponding to the cleaved~19 and 14 kDa PrP products was expected in CH1641, since the N-terminal P4 antibody (93-99) was used. P4 recognizes an epitope known to be removed in BSE, and to a larger extent in CH1641, even when analysed by immunohistochemistry (Jeffrey et al., 2006) . Although we used much higher concentrations of TL than Owen et al. (2007b) , we also clearly identified partially truncated PrP res_TL fragments .20 kDa in CH1641 using the SAF84 antibody, whereas no PrP signal at all was detected by Owen et al. (2007b) in CH1641 using the P4 antibody. This might be due to lower levels of PrP d in the ovine cerebellum sample used in this latter study than those observed in the whole brain of ovine transgenic mice in our study. Overall, among scrapie sources, CH1641 did not show any remarkable feature identified by TL digestion in our study. In contrast, our study confirms previous reports of the remarkable resistance of the BSE strain to TL, after transmission in sheep (Owen et al., 2007b) or in humans with variant CJD (Cronier et al., 2008) . Further studies using more quantitative methods for the detection of TL-resistant PrP products, such as ELISA approaches already available after PK digestion (Simon et al., 2008) , could help to investigate the usefulness of TL in molecular studies of TSEs.
Altogether, this study demonstrates that the TSE strainspecific molecular features of the prion protein, including the variations in gel mobility or the presence of additional C-terminal PrP d fragments, arise from the endogenous proteolytic processing of the pathogenic isoform of prion protein, rather than from differences in the in vitro cleavages of PrP d by proteases. 
